期刊文献+

多聚精氨酸蛋白转导域-凋亡素融合蛋白的原核表达及其生物活性 被引量:3

Prokaryotic Expression and Biological Activity of Poly-Arg Protein Transduction Domain-Apoptin Fusion Protein
原文传递
导出
摘要 目的原核表达多聚精氨酸蛋白转导域-凋亡素融合蛋白,并检测其生物活性。方法应用PCR法扩增Arg9-VP3序列,与载体pET-43.1a连接后,转化E.coliBL21(DE3),IPTG诱导表达。表达产物经Ni2+-NTA纯化后,进行肠激酶裂解、超滤浓缩,并检测其生物活性。结果重组表达质粒pET-43.1a-Arg9-VP3经酶切鉴定和序列分析,证明构建正确。转化E.coliBL21(DE3)后,重组蛋白获得可溶性表达。纯化的融合蛋白纯度达90%以上,可抑制HeLa细胞增殖。结论已成功地在大肠杆菌中表达了多聚精氨酸蛋白转导域-凋亡素融合蛋白,纯化的融合蛋白具有诱导HeLa细胞凋亡的能力。 Objective To express poly-Arg protein transduction domain (PTD)-apoptin fusion protein in prokaryotic cells and determine its biological activity. Methods Arg9-VP3 sequence was amplified by PCR and inserted into vector pET-43.1a, and the constructed recombinant plasmid pET43.1a-Arg9-VP3 was transformed to E. coli BL21 (DE3) for expression under induction of IPTG. The expressed product was purified by Ni2+-NTA chromatography, lysed with enterokinase, concentrated by ultrafiltration and determined for biological activity. Results Both restriction analysis and sequencing proved that recombinant plasmid pET43.1a-Arg9-VP3 was constructed correctly. Recombinant fusion protein was expressed in a soluble form, reached a purity of more than 90% after purification and showed inhibitory effect on the proliferation of HeLa cells. Conclusion Poly-Arg PTD-apoptin fusion protein was successfully expressed in E. coli and purified , which induced the apoptosis of HeLa cells.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第5期448-451,共4页 Chinese Journal of Biologicals
关键词 多聚精氨酸 蛋白转导域 凋亡素 融合蛋白 原核表达 生物活性 Poly-Arg Protein transduction domain (PTD) Apoptin Fusion protein Prokaryotic expression Biological activity
  • 相关文献

参考文献12

  • 1Schwarze SR, Dowdy SF. In vivo protein transduction:intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci, 2000, 21(2): 45-48.
  • 2Green M, Loewenstein PM. Autonomous funetional domains of chemically synthesized human immunodefieieney virus tat transactivator protein. Cell, 1988, 55(6): 1179-1188.
  • 3Derossi D, Joliot AH, Chassaing G, et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem, 1994, 269(14): 10444-10450.
  • 4Wright LR, Rothbard JB, Wender PA. Guanidinium rich peptide transporters and drug delivery. Curr Protein Pept Sci, 2003, 4(2): 105-124.
  • 5Vives E, Richard JP, Rispal C, et al. TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci, 2003, 4(2): 125-132.
  • 6Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev, 2005, 57(4): 559-577.
  • 7Baekendorf C, Visser AE, De Boer AG, et al. Noteborn M apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharrnacol Toxieol, 2008, 48: 143-169.
  • 8Deshayes S, Plenat T, Charnet P, et al. Formation of transmembrahe ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration. Biochim Biophys Acta, 2006, 1758( 11 ): 1846-1851.
  • 9Henriques ST, Quintas A, Bagatolli LA, et al. Energy independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1. Mol Membr Biol, 2007, 24(4): 282-293.
  • 10Futaki S, Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv Drug Deliv Rev, 2005, 57 (4): 547-558.

同被引文献11

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部